Patsnap is a global, pre-IPO company that transforms the way organizations harness their Intellectual Property and Research & Development productivity. Our platform revolutionizes how IP and R&D teams collaborate across the entire innovation lifecycle, using domain-specific AI to accelerate the creation of market-ready products. With over 12,000 customers worldwide, including some of the biggest names in innovation, Patsnap is at the forefront of technological advancement. Our $300M Series E funding round brings our valuation to a $1 billion unicorn status, and we still have a remarkable amount of growth ahead.
As the leading global Life Sciences intelligence platform, Patsnap helps pharmaceutical, biotech, medical device, and life sciences organisations make better innovation decisions. By connecting patents, scientific literature, clinical trials, regulatory data, and market intelligence, we enable our customers to identify white spaces, reduce R&D risk, and accelerate breakthrough innovation.
We have a vibrant and diverse team with offices in Singapore, Toronto, London, Shanghai and remote teams based in US. Our hyper-growth trajectory is powered by our people, and we are extremely proud of our company-wide vision, work ethic, and entrepreneurial spirit. We are committed to fostering an inclusive environment where talent thrives and ideas bloom.
